Proof of Concept Study of AX-158 in Patients With Mild to Moderate Plaque Psoriasis

NCT05725057 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis
Plaque Psoriasis

Interventions

DRUG: AX-158
DRUG: Placebo

Sponsor

Artax Biopharma Inc